Filter
1189
Filtered Results: 1189
Text search:
National
AIDS
Control
Organisation,
Government
of
India
Featured
Recommendations
91
New Publications
376
Language
Document type
No document type
797
Studies & Reports
181
Guidelines
89
Manuals
59
Strategic & Response Plan
30
Training Material
12
Situation Updates
7
Fact sheets
6
Resource Platforms
5
Infographics
3
Countries / Regions
India
232
Global
52
Nepal
45
Nigeria
25
Asia
24
Bangladesh
24
South Africa
23
Kenya
21
Myanmar / Burma
21
South–East Asia Region
16
Ethiopia
16
Uganda
12
Africa
11
Malawi
10
Zimbabwe
10
Namibia
10
Indonesia
10
Zambia
9
Sierra Leone
8
Western and Central Europe
8
Mozambique
7
Cambodia
7
Tanzania
7
Liberia
6
Pakistan
6
Senegal
5
Philippines
5
Eastern Europe
5
Thailand
4
Ghana
4
China
4
Rwanda
4
Latin America and the Carribbean
4
Russia
4
Ukraine
3
Afghanistan
3
Congo, Democratic Republic of
3
Sri Lanka
3
Botswana
3
North Macedonia
2
Tajikistan
2
Colombia
2
Mexico
2
Lesotho
2
Syria
2
Burkina Faso
2
Guinea
2
Middle East and North Africa
2
South Sudan
2
Timor Leste/ East Timor
1
Cameroon
1
Iran
1
Albania
1
Canada
1
Laos
1
Kyrgyzstan
1
Morocco
1
Haiti
1
Venezuela
1
Hungary
1
Jordan
1
West and Central Africa
1
Eastern Europe and Central Asia
1
North America
1
Jamaica
1
Norway
1
Portugal
1
East and Southern Africa
1
Argentina
1
Lebanon
1
Vietnam
1
Papua New Guinea
1
Brazil
1
Moldova
1
Sudan
1
Yemen
1
Palestine
1
Georgia
1
Central African Republic
1
Angola
1
Bhutan
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
461
Public Health
84
Clinical Guidelines
82
Women & Child Health
61
Key Resources
46
Capacity Building
14
Pharmacy & Technologies
12
Annual Report MEDBOX
1
Toolboxes
HIV
154
TB
110
Mental Health
70
Disability
48
COVID-19
38
Health Financing Toolbox
35
Global Health Education
32
Caregiver
30
AMR
27
NTDs
25
Planetary Health
18
Pharmacy
17
Refugee
15
NCDs
14
Malaria
14
Rapid Response
12
Natural Hazards
10
Conflict
8
Cholera
6
Ebola & Marburg
6
Specific Hazards
5
Polio
5
Social Ethics
1
2.0 Rapid Response
1
The "Regional Action Plan 2017–2030: Towards a Malaria-Free South-East Asia Region" by the World Health Organization (WHO) outlines a strategic framework to eliminate malaria in the 11 countries of the WHO South-East Asia Region by 2030. It focuses on reducing transmission, particularly of Plasmod...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
Guidelines for national programmes and other stakeholders
Annexes for webposting and CD-Rom distribution with the policy guidelines
World malaria report 2024
recommended
New data from the WHO reveal that an estimated 2.2 billion cases of malaria and 12.7 million deaths have been averted since 2000, but the disease remains a serious global health threat, particularly in the WHO African Region. According to WHO’s latest World malaria report, there were an estimated ...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
13 May 2021
To avoid a reversal of progress from the adverse impacts of the COVID-19 pandemic, new knowledge and lessons from successful programmatic innovations are urgently needed to improve TB prevention and care. Experience can provide evidence for innovative approaches and strategies to mainta...
The provision of safe and efficacious blood and blood components for transfusion or manufacturing use involves a number of processes, from the selection of blood donors and the collection, processing and testing of blood donations to the testing of patient samples, the issue of compatible blood and ...
Global UNIDO Project: Strengthening the local production of essential medicines in least developed and developing countries
This analytical report reviews and discusses the potential role and influence of political commitment in implementing endorsements and conducting policy in the field of tuberculosis (TB) prevention and care. It promotes discussion by comparing and analysing the extent to which selected international...
Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries
In 2015, 26% of the deaths of 5.9 million children who died before reaching their fifth birthday could have been prevented
through addressing environmental risks – a shocking missed opportunity. The prenatal and early childhood period represents
a window of particular vulnerability, where enviro...
Technical Report
AIDS Medicines and diagnostics service
September 2016
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
The WHO Guide on Oral Cholera Vaccines in Mass Immunization Campaigns provides guidance on the planning and implementation of oral cholera vaccine (OCV) campaigns. It covers key aspects such as when and where to use OCVs, vaccine specifications, and recommendations for use in endemic areas, outbreak...
Circulating vaccine-derived poliovirus type 2 in Angola
Ebola virus disease in Democratic Republic of the Congo
Dengue fever in Côte d’Ivoire
Humanitarian crisis in north-east Nigeria.
These guidelines provide specific recommendations and expert suggestions — for national policy-makers and programme managers and their partners and stakeholders— on prioritizing, planning and providing HIV testing, counselling, treatment and care services for adolescents
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
The Blueprint is intended to guide programming, resource allocation, and commitments to achieve the national objective of a contraceptive prevalence rate (CPR) of 36 percent by 2018.
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
